Table 1.
Clinicopathologic characteristics of the HCC patients (n = 190)
| Characteristic | No. (%) |
|---|---|
| Age (yr) | 58.1 ± 11.8 |
| Sex | |
| Male | 151 (79.5) |
| Female | 39 (20.1) |
| Etiology | |
| Hepatitis B | 136 (71.6) |
| Hepatitis C | 17 (8.9) |
| Alcohol | 8 (4.2) |
| Others | 30 (15.8) |
| Serum alpha-fetoprotein (IU/mL) | 1,634.6 ± 4,590.4 |
| Serum PIVKA-II (AU/mL) | 661.2 ± 1,528.9 |
| Multiplicity | |
| Absent | 106 (55.8) |
| Present | 31 (16.3) |
| Tumor size (cm)a | 4.6 ± 3.0 |
| Edmondson-Steiner grade | |
| I | 1 (0.5) |
| II | 47 (24.7) |
| III | 122 (64.2) |
| IV | 20 (10.5) |
| Microvascular invasion | |
| Absent | 116 (61.1) |
| Present | 74 (38.9) |
| Major vessel invasionb | |
| Absent | 168 (88.4) |
| Present | 22 (11.6) |
| Follow-up | |
| Recurrencec | 102 (53.7) |
| Deaths due to HCC | 24 (12.6) |
Values are presented as mean ± standard deviation or number (%).
HCC, hepatocellular carcinomas.
a
Size of largest tumor in case of multiple tumors;
b
Main or first order branches of portal vein and/or one or more of right, middle or left hepatic veins;
c
Local recurrence or distant metastasis.